Equities

Jagsonpal Pharmaceuticals Ltd

JAGSNPHARM:NSI

Jagsonpal Pharmaceuticals Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)410.15
  • Today's Change3.15 / 0.77%
  • Shares traded25.63k
  • 1 Year change-3.23%
  • Beta1.7302
Data delayed at least 15 minutes, as of Sep 20 2024 10:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue2,0872,3672,176
OPERATING EXPENSES
Cost of revenue total9361,023898
Selling, general and admin. expenses, total9129931,018
Depreciation/amortization171215
Unusual expense(income)7.67380.42
Other operating expenses, total------
Total operating expense1,8722,0651,931
Operating income215302245
Other, net5.909.781.50
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes299348266
Provision for income taxes748178
Net income after taxes225267189
Minority interest------
Net income before extra. Items225267189
Total extraordinary items------
Net income225267189
Inc.avail. to common excl. extra. Items225267189
Inc.avail. to common incl. extra. Items225267189
EPS RECONCILIATION
Basic/primary weighted average shares262626
Basic/primary eps excl. extra items8.49107.20
Basic/primary eps incl. extra items8.49107.20
Dilution adjustment------
Diluted weighted average shares272626
Diluted eps excl. extra items8.47107.20
Diluted eps incl. extra items8.47107.20
COMMON STOCK DIVIDENDS
DPS - common stock primary issue5.005.004.00
Gross dividend - common stock132131105
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental7.772.782.61
SUPPLEMENTAL INCOME
Depreciation, supplemental171215
Total special items7.6734(0.43)
NORMALISED INCOME
Normalized income before taxes306382266
Effect of special items on income taxes1.907.88(0.13)
Income tax excluding impact of special items768978
Normalized income after tax230293188
Normalized income avail. to common230293188
Basic normalized EPS8.71117.19
Diluted normalized EPS8.69117.19
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.